Bildkälla: Stockfoto

Ascelia Pharma: The lead SPARKLE studies provide the first monthly progress update - Redeye

Ascelia announced that 65 patients has now completed the SPARKLE study. This suggests that Ascelia is on track to achieved 80 patients by March or even late February.

Ascelia announced that 65 patients has now completed the SPARKLE study. This suggests that Ascelia is on track to achieved 80 patients by March or even late February.
Börsvärldens nyhetsbrev
ANNONSER